Monographie - Rolapitant - Stabilis 4.0

Ultimo aggiornamento :
19/11/2024

Antiemetico

Rolapitant

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Varubi

Stati Uniti d’America

Bibliografia

Iniezione

Bibliografia : Rolapitant

	tipo	pubblicazione
3927	Rivista	Wu G,Yeung S,Chen F. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate. Int J Pharm Compound 2017 ; 21, 1 : 66-75.
3928	Rivista	Wu G, Yeung S, Chen F. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride. Int J Pharm Compound 2017 ; 21, 1: 76-82.
4061	Rivista	Wu George, Powers Dan, Yeung S, Chen F, Neelon K. Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride. Int J Pharm Compound 2018 ; 22,1 :86-94
4062	Rivista	Wu George, Powers Dan, Yeung S, Chen F, Neelon K. Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection. Int J Pharm Compound 2018 ;22,1:76-85

Mentions Légales